Anti-DN-7 antibody [EPR5266]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(2 Publications)
Rabbit Recombinant Monoclonal DN-7 antibody. Suitable for IHC-P, WB and reacts with Human samples. Cited in 2 publications.
View Alternative Names
TAF9L, TAF9B, Transcription initiation factor TFIID subunit 9B, Neuronal cell death-related protein 7, Transcription initiation factor TFIID subunit 9-like, Transcription-associated factor TAFII31L, DN-7
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-DN-7 antibody [EPR5266] (AB133239)
Immunohistochemical analysis of DN-7 in paraffin embedded Human cervical carcinoma tissue using ab133239 at a 1/250 dilution.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-DN-7 antibody [EPR5266] (AB133239)
Immunohistochemical analysis of DN-7 in paraffin embedded Human tonsil tissue using ab133239 at a 1/250 dilution.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- WB
Unknown
Western blot - Anti-DN-7 antibody [EPR5266] (AB133239)
All lanes:
Western blot - Anti-DN-7 antibody [EPR5266] (ab133239) at 1/1000 dilution
Lane 1:
293T (Human embryonic kidney epithelial cell) cell lysate at 10 µg
Lane 2:
MCF7 cell lysate at 10 µg
Lane 3:
HeLa cell lysate at 10 µg
Lane 4:
A549 cell lysate at 10 µg
Secondary
All lanes:
HRP labelled goat anti rabbit at 1/2000 dilution
Predicted band size: 28 kDa
false
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
DN-7 contributes to nucleic acid metabolism where it prevents the accumulation of DNA fragments. Its enzymatic activity facilitates the clearance of excess DNA critical for avoiding autoimmune reactions. DN-7 often partners with other nucleases forming transient complexes that enhance its efficacy particularly during the cell apoptosis process. These interactions highlight its importance in maintaining genomic stability.
Pathways
DN-7 integrates into the apoptosis pathway working alongside proteins such as caspases. Through regulated DNA cleavage DN-7 supports the systematic dismantling of cellular components during apoptosis. Another pathway involving DN-7 is DNA repair where it complements proteins like PARP ensuring any nonspecific DNA damage is adequately resolved to maintain genomic integrity.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
OncoTargets and therapy 14:2917-2927 PubMed33958878
2021
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 10:e0129190 PubMed26061048
2015
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com